Dr. Mirza on the Evolving Treatment Landscape in Recurrent Ovarian Cancer OncLive 1:30 4 years ago 177 Далее Скачать
Dr. Mirza on the Rationale for the AVANOVA Trial in Recurrent Ovarian Cancer OncLive 2:11 5 years ago 197 Далее Скачать
Dr. Mirza on Efficacy of Niraparib/Bevacizumab Combo in Recurrent Ovarian Cancer OncLive 2:18 5 years ago 299 Далее Скачать
Dr. Mirza on Final Data of the NSGO-AVANOVA2/ENGOT-OV24 Trial in Ovarian Cancer OncLive 2:18 4 years ago 101 Далее Скачать
Advances in the Treatment Landscape of Ovarian Cancer Over Last 30 Years Targeted Oncology 2:28 6 years ago 26 Далее Скачать
Dr. Mirza on Safety Profile of Niraparib/Bevacizumab in Recurrent Ovarian Cancer OncLive 0:52 4 years ago 112 Далее Скачать
An Overview of the Ovarian Cancer Treatment Landscape Pharmacy Times TV 2:42 5 years ago 40 Далее Скачать
Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer PeerView Oncology 34:13 4 years ago 151 Далее Скачать
Dr. Mirza Discusses Niraparib Dose Modifications for Ovarian Cancer Patients With Low Body Weight OncLive 2:26 6 years ago 394 Далее Скачать
The Changing Field of Endometrial Cancer Treatment- 2024 Ovarian Cancer Program GRACE - Global Resource for Advancing Cancer Education 5:42 1 month ago 25 Далее Скачать
Strategies for Managing Recurrent Ovarian Cancer SHARE Cancer Support 1:00:19 4 years ago 1 185 Далее Скачать
Treatment of Recurrent Ovarian Cancer Dr. Faisal Azzam Day1 2021 POCR oncology 23:57 3 years ago 90 Далее Скачать
Dr. Mirza on Niraparib Efficacy Across Ovarian Cancer Subgroups OncLive 1:30 7 years ago 221 Далее Скачать
Dr. Mirza on the Implications of the NSGO-AVANOVA2/ENGOT-OV24 Trial in Ovarian Cancer OncLive 0:56 4 years ago 54 Далее Скачать
